Medical treatment for small abdominal aortic aneurysms

G Rughani, L Robertson… - Cochrane database of …, 2012 - cochranelibrary.com
Background Screening for abdominal aortic aneurysm (AAA) in selected groups is now
performed in England, the USA and Sweden. Patients with aneurysms over 55 mm in …

Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms

CP Twine, IM Williams - Journal of British Surgery, 2011 - academic.oup.com
Background The aim was to investigate the effects of statin therapy on abdominal aortic
aneurysm (AAA) disease. Methods PubMed, the Cochrane Library, Embase and …

Trends in incidence and mortality from abdominal aortic aneurysm in New Zealand

P Sandiford, D Mosquera, D Bramley - Journal of British Surgery, 2011 - academic.oup.com
Background This study examined trends in abdominal aortic aneurysm (AAA) incidence and
mortality in New Zealand (NZ) and compared these with mortality rates from England and …

Pharmacological inhibitor of notch signaling stabilizes the progression of small abdominal aortic aneurysm in a mouse model

J Cheng, SN Koenig, HS Kuivaniemi… - Journal of the …, 2014 - Am Heart Assoc
Background The progression of abdominal aortic aneurysm (AAA) involves a sustained
influx of proinflammatory macrophages, which exacerbate tissue injury by releasing …

Smooth muscle cell-specific Notch1 haploinsufficiency restricts the progression of abdominal aortic aneurysm by modulating CTGF expression

J Sachdeva, A Mahajan, J Cheng, JT Baeten, B Lilly… - PloS one, 2017 - journals.plos.org
Aims Infiltration of macrophages and apoptosis of vascular smooth muscle cells (VSMCs)
promote the development of abdominal aortic aneurysm (AAA). Previously, we …

[HTML][HTML] Pharmacological interventions to attenuate the expansion of abdominal aortic aneurysm (AAA)–a systematic review

D Bergqvist - European Journal of Vascular and Endovascular …, 2011 - Elsevier
INTRODUCTION: Is it possible by pharmacological methods to attenuate the expansion rate
of abdominal aortic aneurysms? METHOD: An Internet-based systematic literature search …

[HTML][HTML] Endovascular aneurysm repair reverses the increased titer and the inflammatory activity of interleukin-1α in the serum of patients with abdominal aortic …

CM Yates, M Abdelhamid, DJ Adam, GB Nash… - Journal of vascular …, 2011 - Elsevier
OBJECTIVE: To examine serum cytokine/chemokine profiles before and 6 months after
endovascular repair (EVAR) of abdominal aortic aneurysm (AAA) and to determine whether …

Asymptomatic abdominal aortic aneurysms show histological signs of progression: a quantitative histochemical analysis

L Eberlová, Z Tonar, K Witter, V Křížková, L Nedorost… - Pathobiology, 2012 - karger.com
Objective: Abdominal aortic aneurysm (AAA) is a serious disease due to its covert nature,
relatively high prevalence and fatal prognosis in the case of rupture. To obtain new insights …

[HTML][HTML] Effect of lipid-modifying drug therapy on survival after abdominal aortic aneurysm repair

GM Parmar, B Lowman, BR Combs, SM Taylor… - Journal of Vascular …, 2013 - Elsevier
Background Lipid-modifying drug therapy (LMDT) is recommended in all patients having
coronary or noncoronary atherosclerotic disease. However, the effect of LMDT after …

[PDF][PDF] Tratamento farmacológico e interações medicamentosas em pacientes com aneurisma da aorta abdominal

HA Peres, SHR de Castro - Infarma-Ciências Farmacêuticas, 2015 - researchgate.net
RESUMO O aneurisma da aorta abdominal (AAA) ocorre quando há uma dilatação anormal
e irreversível da artéria superior a 50% do calibre esperado para o vaso e associa-se a uma …